{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T15:29:44Z","timestamp":1767972584613,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T00:00:00Z","timestamp":1489017600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"FAPERJ","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.vaccine.2017.03.018","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T21:18:00Z","timestamp":1490303880000},"page":"3140-3145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Propagation of Brazilian Zika virus strains in static and suspension cultures using Vero and BHK cells"],"prefix":"10.1016","volume":"36","author":[{"given":"Alexander","family":"Nikolay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leda R.","family":"Castilho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udo","family":"Reichl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Genzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.03.018_b0005","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3201\/eid1705.101939","article-title":"Probable non-vector-borne transmission of Zika virus, Colorado, USA","volume":"17","author":"Foy","year":"2011","journal-title":"Emerg Infectious Diseases"},{"key":"10.1016\/j.vaccine.2017.03.018_b0010","doi-asserted-by":"crossref","unstructured":"Kindhauser MK, Allen T, Frank V, Santhana RS, Dye C. Zika: the origin and spread of a mosquito-borne virus. Bull World Health Organ E-pub. 9.02.2016 ed2016.","DOI":"10.2471\/BLT.16.171082"},{"key":"10.1016\/j.vaccine.2017.03.018_b0015","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barr\u00e9 Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2017.03.018_b0020","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1056\/NEJMoa1600651","article-title":"Zika virus associated with microcephaly","volume":"374","author":"Mlakar","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2017.03.018_b0025","unstructured":"WHO. WHO statement on the first meeting of the International Health Regulations (2005). Emergency Committee on Zika virus and observed increase in neurological disorders and neonatal malformations. <http:\/\/www.who.int\/mediacentre\/news\/statements\/2016\/1st-emergency-committee-zika\/en\/#>; 2016 [25.08.16]."},{"key":"10.1016\/j.vaccine.2017.03.018_b0030","unstructured":"WHO. One year into the Zika outbreak: how an obscure disease became a global health emergency. <http:\/\/www.who.int\/emergencies\/zika-virus\/articles\/one-year-outbreak\/en\/>; 2016 [25.08.16]."},{"key":"10.1016\/j.vaccine.2017.03.018_b0035","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1586\/14760584.2015.1067144","article-title":"Bioreactor concepts for cell culture-based viral vaccine production","volume":"14","author":"Gallo-Ramirez","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2017.03.018_b0040","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/1756-3305-7-382","article-title":"Mosquito cell lines: history, isolation, availability and application to assess the threat of arboviral transmission in the United Kingdom","volume":"7","author":"Walker","year":"2014","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.vaccine.2017.03.018_b0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0166-0934(03)00129-0","article-title":"Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay","volume":"110","author":"Bae","year":"2003","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2017.03.018_b0050","series-title":"Virology methods manual","first-page":"25","article-title":"2 - Virus isolation and quantitation A2 - Mahy, Brian WJ","author":"Hierholzer","year":"1996"},{"key":"10.1016\/j.vaccine.2017.03.018_b0055","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3201\/eid1408.080287","article-title":"Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007","volume":"14","author":"Lanciotti","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2017.03.018_b0060","doi-asserted-by":"crossref","first-page":"10074","DOI":"10.1128\/JVI.74.21.10074-10080.2000","article-title":"Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding","volume":"74","author":"O'Doherty","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.03.018_b0065","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1590\/0074-02760160104","article-title":"Ultrastructure of Zika virus particles in cell cultures","volume":"111","author":"Barreto-Vieira","year":"2016","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2017.03.018_b0070","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1007\/s00253-016-7542-4","article-title":"Influenza virus intracellular replication dynamics, release kinetics, and particle morphology during propagation in MDCK cells","volume":"100","author":"Frensing","year":"2016","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2017.03.018_b0075","article-title":"Inactivation and Environmental Stability of Zika Virus","volume":"22","author":"Janis","year":"2016","journal-title":"Emerg Infect Dis J"},{"key":"10.1016\/j.vaccine.2017.03.018_b0080","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1016\/j.vaccine.2014.02.016","article-title":"High cell density cultivations by alternating tangential flow (ATF) perfusion for influenza A virus production using suspension cells","volume":"32","author":"Genzel","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.03.018_b0085","first-page":"171","article-title":"Production of rabies vaccine by an industrial scale BHK 21 suspension cell culture process","volume":"60","author":"Pay","year":"1985","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2017.03.018_b0090","first-page":"163","article-title":"The use of BHK suspension cells for the commercial production of foot and mouth disease vaccines over a twenty year period","volume":"60","author":"Radlett","year":"1985","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2017.03.018_b0095","unstructured":"WHO. Annex 3 - Recommendations for the evaluation of animal cell cultures as substrates for the manufacture of biological medicinal products and for the characterization of cell banks. (WHO Technical Report Series). <http:\/\/www.who.int\/biologicals\/vaccines\/TRS_978_Annex_3.pdf>; 2013. 978 [13.09.16]."},{"key":"10.1016\/j.vaccine.2017.03.018_b0100","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1099\/0022-1317-42-3-609","article-title":"Virus carrier state suppresses tumorigenicity of tumor cells in athymic (Nude) mice","volume":"42","author":"Reid","year":"1979","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2017.03.018_b0105","first-page":"421","article-title":"BHK-21 cell culture rabies vaccine: immunogenicity of a candidate vaccine for humans","volume":"131","author":"Lalosevic","year":"2008","journal-title":"Dev Biol (Basel)"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.03.018_b0110","first-page":"17","article-title":"Immunogenicity of BHK-rabies vaccine in human volunteers","volume":"51","author":"Lalosevic","year":"1998","journal-title":"Med Pregl"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T23:59:23Z","timestamp":1568937563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17303249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":22,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0264410X17303249"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Propagation of Brazilian Zika virus strains in static and suspension cultures using Vero and BHK cells","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}